1. Home
  2. CCL vs NTRA Comparison

CCL vs NTRA Comparison

Compare CCL & NTRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carnival Corporation

CCL

Carnival Corporation

HOLD

Current Price

$31.57

Market Cap

34.2B

ML Signal

HOLD

Logo Natera Inc.

NTRA

Natera Inc.

HOLD

Current Price

$206.67

Market Cap

32.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCL
NTRA
Founded
1972
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Marine Transportation
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
34.2B
32.9B
IPO Year
1994
2015

Fundamental Metrics

Financial Performance
Metric
CCL
NTRA
Price
$31.57
$206.67
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
20
14
Target Price
$36.05
$253.79
AVG Volume (30 Days)
19.2M
967.7K
Earning Date
03-19-2026
05-19-2026
Dividend Yield
1.83%
N/A
EPS Growth
40.28
0.65
EPS
2.02
N/A
Revenue
$18,881,000,000.00
$210,939,000.00
Revenue This Year
$5.68
$34.18
Revenue Next Year
$3.67
$16.69
P/E Ratio
$16.17
N/A
Revenue Growth
7.83
N/A
52 Week Low
$15.07
$125.38
52 Week High
$34.03
$256.36

Technical Indicators

Market Signals
Indicator
CCL
NTRA
Relative Strength Index (RSI) 49.85 38.69
Support Level $28.11 $195.46
Resistance Level $33.00 $251.09
Average True Range (ATR) 1.19 7.68
MACD -0.16 0.43
Stochastic Oscillator 39.00 35.20

Price Performance

Historical Comparison
CCL
NTRA

About CCL Carnival Corporation

Carnival is the largest global cruise company, with more than 90 ships in service. Its portfolio of brands includes Carnival Cruise Lines, Holland America, Princess Cruises, and Seabourn in North America; P&O Cruises and Cunard Line in the United Kingdom; Aida in Germany; Costa Cruises in Southern Europe. It recently folded its P&O Australia brand into Carnival. The firm also owns Holland America Princess Alaska Tours in Alaska and the Canadian Yukon. Carnival's brands attracted 14 million guests in 2024.

About NTRA Natera Inc.

Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.

Share on Social Networks: